About Biolinq
Biolinq is a company based in San Diego (United States) founded in 2012 by Jared Tangney. Biolinq has raised $279.89 million across 15 funding rounds from investors including Cirrus Logic, HHS and Senvest Capital. Biolinq offers products and services including Biowearable Sensors and Sensor Array Platform. Biolinq operates in a competitive market with competitors including Dexcom, Livongo, Senseonics, One Drop and mySugr, among others.
- Headquarter San Diego, United States
- Founders Jared Tangney
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biolinq Incorporated
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$279.89 M (USD)
in 15 rounds
-
Latest Funding Round
$100 M (USD), Series C
Mar 07, 2025
-
Investors
Cirrus Logic
& 24 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biolinq
Biolinq offers a comprehensive portfolio of products and services, including Biowearable Sensors and Sensor Array Platform.
Sensors for continuous monitoring of metabolic health analytes.
Platform providing real-time feedback for multiple health insights.
People of Biolinq
Unlock access to complete
Unlock access to complete
Funding Insights of Biolinq
Biolinq has successfully raised a total of $279.89M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biolinq
Biolinq has secured backing from 25 investors, including venture fund and institutional investors. Prominent investors backing the company include Cirrus Logic, HHS and Senvest Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on growth-stage companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Healthcare startups are funded by this corporate-backed venture capital entity.
|
Locked | Locked | Locked |
Investor details for Biolinq
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biolinq
Investment portfolio details for Biolinq
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biolinq
Detailed financials for Biolinq
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biolinq Comparisons
Peer comparison for Biolinq
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biolinq
Biolinq operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Senseonics, One Drop and mySugr, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
Detailed competitors of Biolinq
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biolinq
Complete news archive for Biolinq
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolinq
Biolinq was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Biolinq is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Richard Yang is the current CEO of Biolinq.
Biolinq is a funded company, having raised a total of $279.89M across 15 funding rounds to date.
Biolinq was founded in 2012 in San Diego, United States, and operates in the health technology sector. A wearable biosensor platform is developed for diabetes management, featuring a wireless microsensor that tracks metabolism and blood glucose levels continuously. Real-time data is delivered to users via integrated systems, supporting ongoing monitoring without invasive methods. Operations focus on advancing non-invasive glucose sensing technologies.
Biolinq's top competitors include Dexcom, Senseonics and One Drop.
Biolinq offers Biowearable Sensors and Sensor Array Platform.
Biolinq has 25 investors. Key investors include Cirrus Logic, HHS, Senvest Capital, EoFlow, and AXA Investment Managers.